August 28-30, 2017
Philadelphia, PA

Main Conference Day Two

9:00 am - 9:45 am KEYNOTE: Streamlining the Process: Maximize Usability and Minimize Costs from Compounds to Biologics

9:45 am - 10:30 am PANEL DISCUSSION: The Extension of Your Lab: Building Best-Practices for CRO Partnership

Elizabeth Admirand - Principle Research Associate, Lead Discovery Epizyme
img

Elizabeth Admirand

Principle Research Associate, Lead Discovery
Epizyme

11:15 am - 12:00 pm CASE STUDY: The Evolution of Compounds Management at AstraZeneca Boston

Jeff Andrews - Senior Research Scientist AstraZeneca

Jeff Andrews

Senior Research Scientist
AstraZeneca

12:00 pm - 12:45 pm Blending Compound, Biological, and Clinical Sample Storage

1:45 pm - 2:30 pm Integrating Automation and a High-Performance Team within a Compound Management Environment

Jefferson Chin - Analytical Chemist/Lab Manager Bristol-Myers Squibb
img

Jefferson Chin

Analytical Chemist/Lab Manager
Bristol-Myers Squibb

2:30 pm - 3:15 pm Fostering Pre-Competitive Partnerships with Big Pharma and Biobanks to Further Sequencing Efforts

8:00 am - 12:00 am ROUNDTABLE DISCUSSIONS: Join the conversation with your peers on the hottest topics in the industry!

TABLE 1:

Leading Through Change and Organizational Restructuring
Discuss how to build a cohesive, agile team capable of performing during organizational shifts
Focus on the institutional knowledge, retention, ROI, and culture, of both contract staff and company staff


TABLE 2: 

The Lab Of The Future
Employ principles of lean six sigma to assist in reducing non-value-added work from a process level—in lab design


TABLE 3: 

Data Curation
How accurate is your data?  Have you performed an audit?  
Learn the true quality of your data—prior to upgrading your systems  


4:30 pm - 5:15 pm Alliance, Collaborations and Due Diligence for CRO Efforts: Successful Integration into the Discovery Pipeline

Robert Hutchins - Research Scientist I Bristol-Myers Squibb
img

Robert Hutchins

Research Scientist I
Bristol-Myers Squibb